Recombinant Enzyme Therapy for Fabry Disease: Absence of Editing of Human α-Galactosidase A mRNA

類似資料

• Fabry's disease: absence of an -galactosidase isozyme.
  著者:: Wood, S, 等
  出版事項: (1972)
• Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome
  著者:: Rombach, Saskia M., 等
  出版事項: (2012)
• Elevated globotriaosylsphingosine is a hallmark of Fabry disease
  著者:: Aerts, Johannes M., 等
  出版事項: (2008)
• Letter concerning “Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha”, by Tanaka et al.
  著者:: Linthorst, Gabor E., 等
  出版事項: (2010)
• Nicotiana benthamiana α-galactosidase A1.1 can functionally complement human α-galactosidase A deficiency associated with Fabry disease
  著者:: Kytidou, Kassiani, 等
  出版事項: (2018)